baber/WOPTO huggingface dataset:
Patent DE-69910944-T2 (DE)
Inventor: LAHIRE MICHEL
IPC: F21S8/00
Filed: 1999-09-10
Granted: 2004-09-09
Abstract: The adaptation to a conventional set of three-color traffic lights is to place a reference lamp to one side of the enclosure (5) for the traffic lights (1a,1b,1c). The reference lamp (2) is illuminated at night or at other times of poor visibility, and can be vertical and extend the full height of the set of lights, or be a point source placed beside the central lamp of the set of lights.
Patent DE-69919154-T2 (DE)
Inventor: WHALEY K
IPC: A23L1/0522
Filed: 1999-05-05
Granted: 2005-09-01
Abstract: The present invention is directed to the use of a hydrocolloid composition, particularly a starch composition, which is useful as a viscosifier and/or a stabilizer in food products, particularly cultured dairy products, to products containing such hydrocolloid composition, and to the method of preparing such products. The present invention is also directed to the replacement of at least a portion of the gelatin, gum, and/or non-fat milk solids present in food products with such composition without losing the organoleptic and structural properties of the product.
Patent DE-69919530-T2 (DE)
Inventor: BIAGIOTTI GUGLIELMO
IPC: B65G47/252
Filed: 1999-03-11
Granted: 2005-09-29
Abstract: A description is given of a device for separating from each other a plurality of objects (R) which are adjacent to each other and are being fed in a direction of advance (F) along an advance path (21), comprising a member (37) which is rotatable about an axis of rotation (37A) and is positioned, with respect to the direction of advance, in such a way that it interferes with the articles (R) fed along said advance path. The peripheral velocity of said rotatable member at the point of contact between said member and said articles has a component substantially matching the direction of advance of the articles along said path.
Patent DE-69930451-T2 (DE)
Inventor: HOUGH DAVID
IPC: G01N21/78
Filed: 1999-09-30
Granted: 2006-09-14
Abstract: An apparatus for automatically detecting the presence of a reagent strip (14) having a body fluid sample disposed thereon and for inspecting the reagent strip (14) after the presence of the reagent strip (14) is detected is provided with a detection system adapted to automatically detect the presence of a reagent strip (14) at a reagent strip receiving area (12), a light source (64 or 68) adapted to illuminate the reagent strip (14) after the presence of the reagent strip (14) at the reagent strip receiving area (12) is detected, and a detector (66 or 70) adapted to receive light from the reagent strip (14) when the reagent strip (14) is being illuminated by the light source. The detection system is provided with a light emitting apparatus (30) adapted to illuminate the reagent strip receiving area (12), a detecting apparatus (32) adapted to receive light from the reagent strip receiving area (12) while the reagent strip receiving area (12) is being illuminated by the light emitting apparatus (30) and to generate a detection signal relating to the amount of light detected from the reagent strip receiving area (12), and a circuit (120 or 144, 148) adapted to automatically determine whether a reagent strip (14) is present at the reagent strip receiving area (12) based on the magnitude of the detection signal. <IMAGE>
Patent HU-E027180-T2 (HU)
Title: Irrigation pipe
Inventor: GIUFFRE CARMELO
IPC: A01G25/02
Filed: 2006-10-23
Abstract: Irrigation pipe (1) comprising an elongated pipe element having at least a longitudinal row of delivery holes (101) arranged at predetermined distances and which holes communicate each one with a dripping unit (2) provided inside the pipe (1) and having at least an inlet (402) communicating with the inside of the pipe (1) and at least an outlet (202) communicating with at least a delivery hole (101), wherein inlets (402) of all or a certain amount of dripping units (2) or outlets of all (202) or a certain amount of dripping units (2) communicate with the inner space of the pipe (1) or with all or a certain amount of delivery holes (101) respectively by means of an inlet collecting channel (3) or outlet collecting channel (30) respectively of a segment of said inlet or outlet collecting channel.
Patent HU-E030277-T2 (HU)
Title: Reactive flow static mixer with cross-flow obstructions and method for mixing
Inventor: GILLIS PAUL A
IPC: B01F5/06
Filed: 2011-09-28
Abstract: Embodiments of the present invention relate to a mixing apparatus. Particularly, embodiments of the present invention provide a mixing apparatus for mixing fluid components such as phosgene and amine during a highly reactive chemical reaction. One embodiment provides a mixing conduit (100) comprising a cylindrical sidewall (101, 201) defining an inner volume, wherein one or more jets are formed through the cylindrical sidewalls and connect to the inner volume and one or more flow obstructions (103, 203) disposed in the inner volume, wherein each flow obstruction is positioned upstream from an associated aperture (102, 202). 
     More particularly, the prlurality of flow obstructions comprises a plurality of spokes (103, 203) inserted into the inner volume along the circumference of the cylindrical sidewall (101, 201), the plurality of spokes being coupled to a torpedo (212) disposed along a central axis (206) of the mixing conduit.
Patent HU-E033575-T2 (HU)
Title: Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
Inventor: WU FRANK
IPC: A61P35/00
Filed: 2012-05-28
Abstract: The invention relates to a quinazoline derivative represented by the general formula (I), a pharmaceutical acceptable salt and a stereoisomer thereof as tyrosine kinase inhibitor, wherein R 1 , R 2 , R 3 , R 3' , R 4 , R 5 , R 6 , X, L, T, Z and q are as defined in the specification. The invention also relates to a process for preparing the same, a pharmaceutical composition and a pharmaceutical formulation containing the derivative, use of the derivative for treating excessive proliferative diseases and chronic obstructive pulmonary disease and use of the derivative in the manufacture of a medicament for treating excessive proliferative diseases and chronic obstructive pulmonary disease.
Patent SI-1951296-T2 (SI)
Title: Cell-derived viral vaccines with low levels of residual cell dna by betapropiolactone
Inventor: GREGERSEN JENS-PETER
IPC: A61K39/00
Filed: 2006-11-01
Abstract: The present invention relates to vaccine products for the treatment or prevention of viral infections. Further provided are methods of reducing contaminants associated with the preparation of cell culture vaccines. Residual functional cell culture DNA is degraded by treatment with a DNA alkylating agent, such as ²-propiolactone (BPL), thereby providing a vaccine comprising immunogenic proteins derived from a virus propagated on cell culture, substantially free of residual functional cell culture DNA.
Patent TR-200100650-T2 (TR)
Inventor: KARLSSON LARS
IPC: F41H3/02
Filed: 1999-09-03
Abstract: The invention regards a material having a three-dimensional surface built up by bulgings arranged regularly or irregularly mutually adjacently, and which have approximately conical form. It is thus accomplished that the brightness of the material is little dependent on the view angle, in contrast to what is the case with plane surfaces, even if painted with matte camouflage paint.
Patent TR-200102522-T2 (TR)
Inventor: OR YAT SUN
IPC: A61P31/04
Filed: 2000-03-08
Abstract: The instant invention provides novel macrolide compounds and compositions useful in treating bacterial infections. Also provided are processes for preparing same. These macrolides are substituted on the 6-O-position with X'-Y'-Z', wherein X' is selected from the group consisting of C1-C10 alkyl, C3-C10 alkenyl, and C3-C10 alkynyl; Y' and Z' are independently selected from the group consisting of: (c) optionally substituted aryl, and (d) optionally substituted heteroaryl, with the proviso that both Y' and Z' are not both phenyl, and with the further proviso that Y' is not isoxazole when Z' is thiophenyl.
Patent TR-200103794-T2 (TR)
Title: Buzdolabı gövde içi hava dağılımı.
Inventor: DINGEC HALDUN
IPC: F25D17/08
Filed: 2000-06-05
Abstract: Buzdolabinda bulunan hava gelis kanalina (1), hava geçis menfezleri (2) yapilmis ve raflar (5) bu hava geçis menfezlerine (2) karsilik gelecek sekilde siki geçme veya conta ile hava gelis kanali baglantisi (3) araciligi ile monte edilmistir. Sözü edilen raflarin (5) alt ve/veya üst bölümlerine delikler (4) enine veya boyuna olacak sekilde yerlestirilmistir. Fan (7) ile gövdedeki hava gelis kanalina (1) üflenen hava, hava geçis menfezleri (2) yardimi ile raflarin (5) içinde olusturulan deliklere (4) aktarilmaktadir. Üflenen havanin buzdolabi içine ulasmasini saglamak için raflar (5) üzerinde degisik sayi ve büyüklüklerde delikler (4) açilmistir. Raflar (5) üzerindeki delikler (4) yardimi ile alt veya üst tarafta kalan sogutulacak hacme havanin esit dagilimda üflenmesi saglanmaktadir.
Patent TR-200200977-T2 (TR)
Title: Beta konumunda iki kere sübstitüe edilmiş metaloproteaz engelleyiciler
Inventor: PIKUL STANISLAW
IPC: A61K31/421
Filed: 2000-10-12
Abstract: Metaloproteazlarin engelleyicileri olan ve özelligi, bu enzimlerin asiri etkinligi olan sartlarin tedavisinde etkili terkipler ifsa edilmistir.Özel olarak terkiplerin (I) Formülüne uygun bir yapisi vardir; bu formüldeki R1,R2,R3,R4,R5,R6,G ve Z spesifikasyonda tarif edilen anlamlari haizdir.Bu bulus (I) formülünün optik izomerlerini, diastereomerlerini ve enansiyomerlerini de farmasötik olarak kabul edilebilir tuzlarini, biyolojik olarak hidroliz yapilabilir amitleri, esterleri ve imitlerini de içerir. Bu terkipleri ihtiva eden farmasötik bilesimler ve terkipleri veya farmasötik bilesimleri kullanarak metaloproteazlarla baglantili hastaliklari tedavi yöntemleri de tarif edilmistir.
Patent DE-602004000123-T2 (DE)
Inventor: KORNBLIT AVINOAM
IPC: G02B27/00
Filed: 2004-02-20
Granted: 2006-06-29
Abstract: An adjustable compound optical microlens apparatus comprises first and second microlenses that are separated from one another along their optical axes. At least one of the microlenses is movable relative to the other. In a preferred embodiment, one microlens is stationary, the other movable. A MEMS controller electrically controls the position of the movable microlens relative to the stationary microlens, or the positions of at least two movable microlenses relative to one another. In a preferred embodiment, one microlens element is stationary, the other movable. A MEMS controller electrically controls the position of the movable microlens relative to the other. In accordance with one embodiment of our invention, an array of such microlens apparatuses is also contemplated, especially for applications such optical switches and routers. In accordance with another embodiment of our invention, the facing optical surfaces of the microlenses include partially transmissive metal coatings, so that the apparatus functions as an optical filter or dispersion compensator. Also described is method of compensating for variations in an optical parameter (e.g., effective focal length) of a first apparatus in an array comprises the steps of: (a) determining that the first apparatus in the array has a value of the parameter different from a predetermined standard value; and (b) applying an electrical signal to the MEMS controller of the first apparatus, thereby causing the controller to perform a mechanical action that makes the value of the parameter of the first apparatus closer to the standard value. (Illustratively, the mechanical action alters the separation and/or tilt between a pair of microlenses in the first apparatus.) In one embodiment, the standard value is stored (for example, in a computer), and in another embodiment it is determined by the value of the same parameter of a second apparatus in the array. <IMAGE> <IMAGE>
Patent DE-602004003085-T2 (DE)
Inventor: UENO TAKASHI
IPC: A61M25/00
Filed: 2004-03-26
Granted: 2007-06-06
Abstract: A catheter (20), which is to be percutaneously inserted into a living body lumen, comprises: a sheath portion (55) having a lumen extending therein; an insertion member (60) slidably disposed in said lumen and having a distal end portion (62) capable of protruding from a distal end portion (57) of said sheath portion (55); an injection needle (63) disposed at said distal end portion (62) of said insertion member (60) for injecting a therapeutic composition into a target tissue in a living body; and an electrode (70) for measuring a cardiac action potential. The electrode (70) is disposed at said distal end portion (62) of said insertion member (60) and is spaced from or adjacent to a bevel of said injection needle (63) along a longitudinal direction of said insertion member (60).
Patent DE-602004006555-T2 (DE)
Inventor: MERENLENDER YUVAL
IPC: G09F7/18
Filed: 2004-04-08
Granted: 2008-01-31
Abstract: An illuminated display (11) device includes an upper horizontal mount (18) and a lower horizontal mount (19) supported by a vertical pole (13) with two opposite-facing translucent banners (21,23) suspended between the mounts. The upper mount (18) supports an enclosure which includes illumination (17) means for projecting light downwardly. Two banners (21,23) of substantially equal length are suspended between the supports and are disposed at an angle to each other, being spaced apart a greater distance at the top than at the bottom. The inside angled surfaces of each banner (21,23) receive light projected downwardly from the enclosure. The enclosure may also include translucent side surfaces which can carry an advertising display or other printed communication to supplement the information provided on the outside surfaces of the banners. The banners (21,23) are suspended between the mounting means by rod-and-hook attachments so that the banners can be easily removed and replaced. Resilient suspension of the banner is provided both by the resilience of the banner material itself and also by the resilience of the support arms. The banners are convergent in the downward direction at an included angle of approximately 20 degrees. <IMAGE>
Patent DE-602004007672-T2 (DE)
Inventor: JOHNSON CHRISTOPHER NORBERT
IPC: C07D215/40
Filed: 2004-09-23
Granted: 2008-04-10
Abstract: Disclosed are quinoline compounds of formula (I) having pharmacological activity, processes for their preparation, compositions containing them, and methods for the treatment of CNS and other disorders.
Patent DE-602004007775-T2 (DE)
Inventor: ROY VINCENT
IPC: H04B17/00
Filed: 2004-02-10
Granted: 2008-06-05
Abstract: A method and communication system (e.g., a time-division duplex (TDD) system) that uses adaptive antennas at the base stations to monitor metrics associated with the quality of one or more common physical channel (CPCH) timeslots, so as to determine whether to reuse some or all of the CPCH timeslots to transmit a dedicated physical channel (DPCH). If it is determined to reuse some or all of the CPCH timeslots, an additional determination is made as to what limit to apply on the DPCH transmission powers. Adaptive antennas may be used at the base stations to allow the system to reuse some or all of the CPCH timeslots to transmit DPCH, thus improving the overall capacity of the system while maintaining the CPCH coverage and quality at a desired level throughout the system.
Patent DE-602005003576-T2 (DE)
Inventor: YACH DAVID
IPC: G06Q10/00
Filed: 2005-09-01
Granted: 2008-10-23
Abstract: A method and communications device is provided for determining a list of possible additional recipients to add to an electronic message that is composed by a user of the communications device for transmission to another communications device. Once the user indicates that there is an additional recipient for the distribution list of the electronic message, the device employs the method to create the list of possible additional recipients. The method may be implemented on a computer program product.
Patent DE-602006000111-T2 (DE)
Inventor: DION DOMINIQUE
IPC: F42B14/02
Filed: 2006-01-18
Granted: 2008-06-19
Abstract: The seal band, comprising an anti-slip ring (6) that turns on a support (5), incorporates a copper ring (7) of the same diameter as the gun barrel. The copper ring, which has a thickness no more than 5 per cent of the barrel calibre, is located in front of the anti-slip ring and is of smaller diameter than the latter. It is held at a set distance from the anti-slip ring by a spacer (8).
Patent DE-60225586-T3 (DE)
Inventor: ARTS GERT-JAN
IPC: C12N15/11
Filed: 2002-08-29
Granted: 2015-12-03
Abstract: Isolated polynucleotides, and vectors including the same, are disclosed as useful for down-regulation of specific RNA in cells, including a first sequence of about 17 to about 23 nucleotides, complementary to said RNA, and linked to a second sequence capable of forming a loop when said second sequence is RNA. The polynucleotides include self-complementing single-stranded polynucleotides, including a third sequence linked by said second sequence where all nucleotides in said first and said third sequences are complementary. Functional genomic, diagnostic and therapeutic methods are disclosed that involve reducing the amount of a unique RNA sequence in cells using a vector encoding the self-complementing polynucleotide including a first sequence complementary to said RNA sequence. Methods are also disclosed for preparing the polynucleotides, vectors, libraries of vectors, and the temporary knock-down of proteins, such as lethal proteins, during virus or recombinant protein production.
Patent DE-69302961-T3 (DE)
Inventor: BETTATI TIENNO
IPC: B65G17/08
Filed: 1993-04-09
Granted: 2001-04-19
Abstract: Conveyor chain, including multiple links that are shaped like a sort of fork (3) whose aperture is closed, from the active part of the link, by a monolithic plate (4), and where said links are connected by pins (5) that are situated transversally to the arms (31) of said forks, and that are inserted into the respective seats (7) of articulation and oscillation situated on the crosspieces (30) of said forks, and said pin (5) has a partially cylindrical shape, while said seat (7) has a central narrowing (71) that faces the non-cylindrical part of said pin (5). <IMAGE>
Patent DK-1101784-T3 (DK)
Inventor: KAUFHOLD WOLFGANG
IPC: C08G18/75
Filed: 2000-11-09
Granted: 2007-09-10
Abstract: Thermoplastic polyurethane has an abrasion resistance and elongation at break at least 60% of the initial values after storage in heat and at least 80% after hydrolysis storage at 80 degrees C for 7 days, a Tg of at most -50 degrees C and a Shore A hardness of 70-95. Thermoplastic polyurethane (PU) has an abrasion resistance and elongation at break at least 60% of the initial values after storage in heat and at least 80% after hydrolysis storage at 80 degrees C for 7 days, a Tg of at most -50 degrees C and a Shore A hardness of 70-95. Independent claims are included for the continuous production of the above PU by mixing the polyol(s) and chain extender and mixing with diisocyanate(s) within 5 s at 60-50 degrees C and optionally granulating and molded articles made from the above PU.
Patent DK-1101473-T3 (DK)
Inventor: WADA MITSUHIRO
IPC: A61F13/20
Filed: 2000-11-08
Granted: 2009-10-05
Abstract: Provided is an applicator for a tampon including an outer cylinder having a large diameter portion for fitting a tampon therein, a small diameter portion provided on the side of a rear end of the outer cylinder and having a smaller diameter than that of the large diameter portion; and a plurality of valves provided on the side of a leading end of the outer cylinder. The valves are converged to have a curved face portion to be diametrically gradually reduced toward the leading end of the outer cylinder, and a push-out member is movably inserted into the small diameter portion of the outer cylinder. A ratio A/B is at most 0.8, when an inflection point for the boundary between the maximum diameter portion of the large diameter portion and the curved face portion is designated by Z, a radius of the outer face at the inflection point Z is designated by A, and the axial length from the inflection point Z to the leading end of the curved face portion is designated by B. A ratio L/W is within a range of 1.0 to 2.0, when the width size of root ends of the valves is designated by W and the length of the valves is designated by L.
Patent DK-1140861-T3 (DK)
Inventor: BOUCHARD HERVE
IPC: A61P9/10
Filed: 2000-01-07
Granted: 2003-10-20
Abstract: The invention concerns novel derivatives offormula (I) wherein: R1 represents the stereoisomeric forms of the chain -(CHOH)3-CH2-O-COR (II) and either R2 represents a hydrogen atom and R3 represents the stereoisomeric forms of the chain -CH2-(CHOH)2-CH2-O-COR (III) or R2 represents the stereoisomeric forms of the chains -(CHOH)3-CH2-O-COR (II) or -CH2-(CHOH)2-CH2-O-COR (III) and R3 represents a hydrogen atom and R represents -(Alk)1-(Cycloalk) radical; i is equal to 0 or 1; Alk represents and alkyl radical, Cycloalk represents a cycloalkyl radical, and their salts with a inorganic or organic acid, their preparation and the medicines containing as active principle at least a product of general formula (I) or its salts with a inorganic or organic acid.
Patent DK-1150738-T3 (DK)
Inventor: BRANDAU WOLFGANG
IPC: A61K9/22
Filed: 2000-02-17
Granted: 2002-12-30
Abstract: An implant is suggested having a receptacle space for a therapeutic agent, which can leave the receptacle space through a permeable element. For exact dosage, an open-pore diffusion element is suggested as the permeable element, wherein the pore walls are chemically modified for control of the diffusion.
Patent DK-1185630-T3 (DK)
Inventor: CALLISEN THOMAS HONGER
IPC: C12N9/20
Filed: 2000-06-02
Granted: 2009-03-30
Abstract: Lipolytic enzymes are chemically modified by covalently linking one or more (particularly 1-3) hydrophobic groups to the enzyme molecule. The chemical modification improves the performance of the lipolytic enzyme, e.g., in baking or in detergents.
Patent DK-1206200-T3 (DK)
Inventor: ARNOLD DEREK LESLIE
IPC: A42B3/24
Filed: 2000-08-24
Granted: 2004-08-30
Abstract: Visor assembly (1, 21) consisting of having an inner shield (6, 26) and an outer shield (2, 22). In the use position these shields are some distance apart. With this arrangement the inner shield (6, 26) is located within the peripheral confines of the outer shield (2, 22). The inner shield (6, 26) is provided with an elevation (7, 27) which extends close to the periphery thereof and which acts as a spacer with respect to the outer shield. This elevation (7, 27) is preferably made of silicone material which is snack to the inner shield (6, 26) but is not stuck to the outer shield (2, 22). Fixing to the outer shield (2, 22) takes place by means (10, 12) of via mechanical fixing means.
Patent DK-1156789-T3 (DK)
Inventor: BOULIKAS TENI
IPC: A61K33/243
Filed: 2000-10-27
Granted: 2006-08-07
Abstract: A method for encapsulating cisplatin and other positively-charged drugs into liposomes having a different lipid composition between their inner and outer membrane bilayers is disclosed. The liposomes are able to reach primary tumors and their metastases after intravenous injection to animals and humans. The encapsulated cisplatin has a high therapeutic efficacy in eradicating a variety of solid human tumors including but not limited to breast carcinoma and prostate carcinoma. Combination of the encapsulated cisplatin with encapsulated doxorubicin or with other antineoplastic drugs are claimed to be of therapeutic value. Also of therapeutic value in cancer eradication are claimed to be combinations of encapsulated cisplatin with a number of anticancer genes including but not limited to p53, IL-2, IL-12, angiostatin, and oncostatin encapsulated into liposomes as well as combinations of encapsulated cisplatin with HSV-tk plus encapsulated ganciclovir.